Last updated 16 days ago

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder

550 patients around the world
Available in Argentina, Mexico, United States, Brazil
Janssen Research & Development, LLC
30Research sites
550Patients around the world
This study is for people with
Bladder Cancer
Muscle-Invasive Bladder Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Dorrego 269, La Rioja
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
25 de mayo 174, Viedma, Río Negro
Fundación Intecnus
Recruiting
RP82 8400, San Carlos de Bariloche, Río Negro
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Av. Crámer 1180, CABA, Buenos Aires
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Recruiting
Juan Domingo Perón 4190, Piso 1, Ciudad Autónoma de Buenos Aires, C1181ACH
Sanatorio Allende (Cerro)
Recruiting
Pedro Simón Laplace 5749, Córdoba
Centro de Investigación Pergamino SA
Recruiting
Av. de Mayo 1115, Pergamino, Buenos Aires
INSCER - Instituto do Cérebro da PUC-RS
Recruiting
Av. Ipiranga, 6690, 4o Andar, Centro de Pesquisa Clínica do HSLPUCRS - Jardim Botânico – Porto Alegre/RS - 90610-000
Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO
Recruiting
Av. Príncipe de Gales, 821 - Vila Principe de Gales, Santo André - SP, 09060-650
Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE
Recruiting
Rua Pedro de Toledo, 1800 - Vila Clementino, São Paulo - SP, 04039-000
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy